501 related articles for article (PubMed ID: 35179662)
41. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
[TBL] [Abstract][Full Text] [Related]
42. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
[TBL] [Abstract][Full Text] [Related]
43. Clinical features of macrophage activation syndrome in the adult northern Chinese population.
Li X; Qu B; Nie Y; Zhu G; Li W; Mu F
Lupus; 2014 Jul; 23(8):785-92. PubMed ID: 24682586
[TBL] [Abstract][Full Text] [Related]
44. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis.
Gerstein M; Borgia RE; Dominguez D; Feldman BM; Liao F; Levy DM; Ng L; Abdelhaleem M; Silverman ED; Hiraki LT
J Rheumatol; 2021 Sep; 48(9):1450-1457. PubMed ID: 33262295
[TBL] [Abstract][Full Text] [Related]
45. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
[TBL] [Abstract][Full Text] [Related]
46. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
47. [Macrophage activation syndrome: report on three cases].
Zietkiewicz M; Hajduk A; Wojteczek A; Smoleńska Z; Czuszyńska Z; Zdrojewski Z
Ann Acad Med Stetin; 2012; 58(1):55-61. PubMed ID: 23547396
[TBL] [Abstract][Full Text] [Related]
48. [Intravenous immunoglobulin in macrophage activation syndrome associated with systemic lupus erythematosus].
Mendoza-Álvarez SA; Galindo-López R; Sánchez-Escalona D; Velázquez-Santiago Y; Sánchez-Rodríguez AS
Rev Med Inst Mex Seguro Soc; 2020 Sep; 58(5):634-643. PubMed ID: 34520152
[TBL] [Abstract][Full Text] [Related]
49. Anti-ribosomal P protein antibodies in patients with systemic lupus erythematosus is associated with hyperferritinemia.
Arinuma Y; Hirohata S; Isayama T; Hasegawa Y; Muramatsu T; Kondo J; Kanayama Y; Ino K; Matsueda Y; Oku K; Yamaoka K
Int J Rheum Dis; 2022 Jan; 25(1):70-75. PubMed ID: 34796669
[TBL] [Abstract][Full Text] [Related]
50. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
[TBL] [Abstract][Full Text] [Related]
51. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
[TBL] [Abstract][Full Text] [Related]
52. Systemic Lupus Erythematosus in Disguise: Acute Pancreatitis as Initial Presentation.
Abughazaleh S; Alsakarneh S; Hattar M; Jaber F; Palmer Q; Ghoz H
J Investig Med High Impact Case Rep; 2023; 11():23247096231185480. PubMed ID: 37421299
[TBL] [Abstract][Full Text] [Related]
53. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of patients with initial diagnosis of systemic lupus erythematosus in emergency department and their outcomes: a retrospective single-center study.
Zhang X; Song X; Lv S; Li J; Jin Y; Jin J; Shao M; Zhu J; Chi C
Clin Rheumatol; 2024 Feb; 43(2):667-676. PubMed ID: 38150055
[TBL] [Abstract][Full Text] [Related]
55. Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.
Schäfer VS; Weiß K; Krause A; Schmidt WA
Clin Rheumatol; 2018 Jul; 37(7):1835-1844. PubMed ID: 29656375
[TBL] [Abstract][Full Text] [Related]
56. Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study.
Huang LW; Wei JC; Chen DY; Chen YJ; Tang KT; Ko TM; Chen HH
Rheumatology (Oxford); 2022 Mar; 61(3):1123-1132. PubMed ID: 34146089
[TBL] [Abstract][Full Text] [Related]
57. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients.
Zandman-Goddard G; Orbach H; Agmon-Levin N; Boaz M; Amital H; Szekanecz Z; Szucs G; Rovensky J; Kiss E; Corocher N; Doria A; Stojanovich L; Ingegnoli F; Meroni PL; Rozman B; Gomez-Arbesu J; Blank M; Shoenfeld Y
Clin Rev Allergy Immunol; 2013 Feb; 44(1):23-30. PubMed ID: 21394428
[TBL] [Abstract][Full Text] [Related]
58. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.
García-Pavón S; Yamazaki-Nakashimada MA; Báez M; Borjas-Aguilar KL; Murata C
J Pediatr Hematol Oncol; 2017 Aug; 39(6):445-451. PubMed ID: 28562511
[TBL] [Abstract][Full Text] [Related]
59. Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
Gilboa M; Bornstein G; Ben-Zvi I; Grossman C
Rheumatol Int; 2020 Apr; 40(4):663-669. PubMed ID: 31367795
[TBL] [Abstract][Full Text] [Related]
60. Macrophage activation syndrome as a complication of rheumatologic disorders, a report from Iran.
Assari R; Sadeghi P; Mirmohammadsadeghi A; Ebadi F; Ziaee V
Reumatismo; 2020 Jan; 71(4):189-198. PubMed ID: 31995957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
